SUVEN LIFE SCIENCES LIMITED

Transcripts Suven Life Sciences Limited NSE India S.E.

Equities

SUVEN

INE495B01038

Delayed NSE India S.E. Other stock markets 05:41:04 2024-05-02 am EDT			5-day change	1st Jan Change
112.5 ^INR	+1.86%		+5.04%	+39.32%

Apr. 15	Suven Life Sciences to Present Phase-2 Positive Results on Samelisant (SUVN-G3031) at American Academy of Neurology 2024 Annual Meeting, Denver, USA	CI
Feb. 06	Suven Life Sciences Announces Randomization of First Patient in Phase-2 POC Clinical Trial of Ropanicant (SUVN-911) for the Treatment of Moderate to Severe Major Depressive Disorder Study in USA	CI

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Suven Life Sciences Limited, Q1 2024 Earnings Call, Aug 10, 2023	23-08-10
Transcript : Suven Life Sciences Limited, Q4 2023 Earnings Call, May 26, 2023	23-05-25
Transcript : Suven Life Sciences Limited, Q2 2023 Earnings Call, Nov 09, 2022	22-11-09
Transcript : Suven Life Sciences Limited, Q1 2022 Earnings Call, Aug 16, 2021	21-08-16
Suven Life Sciences Limited Provides Earnings Guidance for the Full Year 2021	21-08-16	CI
Transcript : Suven Life Sciences Limited, Q2 2021 Earnings Call, Oct 31, 2020	20-10-31
Transcript : Suven Life Sciences Limited, Q3 2020 Earnings Call, Feb 14, 2020	20-02-14

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Like the pros, access all the transcripts and spot the best opportunities before anyone else.

Unlock them now!

fermer